Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Impact of pharmacist intervention on the utilization of sitagliptin use in the ckd

  • In: Poster presentation
  • At: Seoul (South Korea) (2017)
  • Type: Poster
  • Poster code: POS-HPS-077
  • By: LEE, Chi-Hui (China Taiwan)
  • Co-author(s): Chi-Hui Lee
  • Abstract:

    Background

    Sitagliptin is the first DPP-IV inhibitor and studies have demonstrated that appropriate reductions dose in chronic kidney disease (CKD) patients.

    Purpose

    This study was to evaluate the impacts of pharmacist intervention on sitagliptin utilization in chronic kidney disease .

    Methods

    This study was divided into three periods of repetitive..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses